Approval · Notice of Compliance 21572 · 2018
OPSUMIT: Notice of Compliance 21572
Issued November 28, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21572
- Date
- November 28, 2018
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPSUMIT | 02415690 | Marketed |
Medicinal ingredients
- MACITENTAN 10 MG per TAB